Bud Light used an actor dressed as a medieval town crier last week to ask a Minnesota brewery to stop using the company’s trademarks, becoming the latest brand to transform a cease-and-desist into a marketing stunt.
Three seasoned intellectual property litigators with clients among high-tech companies and financial-services firms have left Morgan & Finnegan to join Chadbourne & Parke LLP’s office in New York as partners, Chadbourne said.
A California federal court has ruled that the design of a Medtronic Inc. spinal implant polyaxial screw infringes a patent held by musculoskeletal products company Biomet Inc.
A Chicago software vendor that has rattled the futures industry with patent litigation has sued U.K.-based Man Group, one of the largest futures brokerages in the world.
The U.S. Food and Drug Administration has granted Barr Laboratories a final approval for a generic version of Aventis Pharmaceuticals' blockbuster allergy medicine Allegra-D, the company said.
A Texas federal court has ruled in favor of Universal Instruments in a patent lawsuit brought by two inventors of a technology used in manufacturing printed circuit boards that are part of computers, cell phones, and other electronic devices.
Chip packaging company Tessera Technologies Inc. has amended its patent infringement suit against Infineon Technologies AG and Micron Technology Inc. to include what it claims are violations of antitrust law and illegal business interference.
Japanese electronics companies Sanyo Electric Co. and Sharp Corp. have joined a DVD patents licensing group that consists of some of the major DVD-related patent holders in the world, the group said Friday.
In a major victory for Eli Lilly & Co., an Indiana federal judge has upheld the patent on the key ingredient on its $4.4 billion-a-year Zyprexa schizophrenia drug.
South Korean authorities have ended an investigation into Japan's Matsushita Electric Industrial Co. and lifted a temporary ban on imports of the company's plasma display panels in the wake of the settlement of a patent dispute between Matsushita and Korea’s LG Electronics.
In a stinging setback for Magma Design Automation, the company’s chief scientist and co-founder has admitted to using ideas he conceived of as an employee of Synopsys when he filed for two patents at the center of a dispute between the two rivals in the semiconductor industry.
An Indiana judge will render his decision Thursday afternoon in Eli Lilly & Co.’s closely watched patent infringement lawsuit against would-be makers of generic versions of the company’s blockbuster schizophrenia treatment Zyprexa.
A California “architect to the stars” has won a copyright infringement lawsuit against a contractor who ripped off one of his designs to surreptitiously build a copycat mansion for himself in Beverly Hills, just a few miles away from the original building.
In a move that could spell trouble for the release of Microsoft’s next operating system, a small data-networking company has been granted a preliminary injunction in a patent infringement lawsuit against the software giant.
Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. have penned an unusual settlement agreement to put an end to their patent litigation over Kos' cholesterol lowering drugs Niaspan and Advicor, the two companies said Wednesday.
Shire Pharmaceuticals Group has decided not to sue Israeli generics maker Teva Pharmaceuticals USA Inc. over its application for a generic version of the best-selling attention deficit drug Adderall XR.
The U.S. Court of Appeals for the Federal Circuit has revived a lawsuit filed by Tyco International Ltd.'s Nellcor unit against Masimo Corp. over a patent for machines that measure the oxygen content in blood.
Generic drug maker Barr Pharmaceuticals Inc. has dropped a lawsuit against the U.S. Food and Drug Administration over exclusive marketing rights to a generic version of Sanofi-Aventis’ allergy treatment Allegra.
In an attempt to crack down on fast-growing cross-border sales of prescription drugs to U.S. consumers, drug maker Merck & Co. has filed a series of lawsuits against Canadian online pharmacies that ship Apotex’ generic version of Zocor south of the border.
Taiwan’s Teco Group has struck back against Japan’s Sharp Corp. in their dispute over patents for LCD television sets, suing the Japanese rival in Tokyo District Court for unfair competition.
The U.S. Court of Appeals for the Federal Circuit has dismissed Canadian generics maker Apotex Inc.’s lawsuit against Pfizer, Inc. after Pfizer covenanted not to sue Apotex for infringement of a patent for the hypertension drug Accupril.